Navigation Links
Scientist receives $2.8 Million to study cell signaling mechanism and develop potential therapeutics
Date:9/17/2012

JUPITER, FL, September 13, 2012 A scientist from the Florida campus of The Scripps Research Institute has been awarded a pair of grants totaling $2.8 million from the National Institute of General Medical Sciences of the National Institutes of Health, and from TargAnox, a Massachusetts-based biotechnology firm.

Kate Carroll, a Scripps Research associate professor, will be the principal investigator for the new projects.

Research funded by both grants will focus on a process known sulfenylation, a relatively new field of research. During periods of cellular stress, caused by factors such as UV radiation or chronic diseases such as cancer, the level of highly reactive oxygen-containing molecules can increase, resulting in inappropriate modification of proteins and cell damage through this process. One oxidant produced naturally in the body, hydrogen peroxide, acts as a messenger that can activate cell proliferation.

In the new research, Carroll will look at cell signaling in sulfenylation and explore ways that it might be modified with potential drug compounds to treat conditions such as lung and breast cancers, as well as be used to diagnose and monitor such diseases.

To explore the process, Carroll and her colleagues have developed a highly selective chemical probeknown as DYn-2 that can detect minute differences in sulfenylation rates within the cell. The new four-year, approximately $1.5 million NIH grant (award number 1R01GM102187-01) will fund work utilizing that chemical probe to fully define the molecular mechanism through which a key signaling protein, epidermal growth factor receptor (EGFR), is modified by hydrogen peroxide.

"The grant from NIH will let us take a closer look at the basic mechanics of the sulfenylation process and detail how oxidation regulates EGFR," Carroll said. "The TargAnox study uses that work as a spring board into potential treatments."

Carroll said she also plans to investigate additional targets of sulfenylation and to test various compounds that can reverse the process.


'/>"/>

Contact: Mika Ono
mikaono@scripps.edu
858-784-2052
Scripps Research Institute
Source:Eurekalert  

Related medicine news :

1. Kessler Foundation scientist garners best poster award for MS research
2. Cardiff scientists bid to develop anthrax vaccine to counteract world bioterrorism threat
3. Scripps Research Institute scientists show protein linked to hunger also implicated in alcoholism
4. Scientists Spot 5 Genes That Help Shape Faces
5. Eight scientists honored in first annual Golden Goose Awards
6. Scientists Map Genetic Blueprint of Heart
7. Scientists use sound waves to levitate liquids, improve pharmaceuticals
8. UCF nanoscientist receives $2 million NIH award
9. Scientists ID Gene for Insulin Sensitivity
10. Hopkins scientists discover how an out-of-tune protein leads to muscle demise in heart failure
11. Scripps Research scientists devise powerful new method for finding therapeutic antibodies
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Scientist receives $2.8 Million to study cell signaling mechanism and develop potential therapeutics
(Date:8/17/2017)... , ... August 17, 2017 , ... Centrifugation is more ... in the laboratory that we can no longer do without. And just like a ... of your device. , In this webinar, attendees will learn about the most important ...
(Date:8/17/2017)... ... August 17, 2017 , ... A recent report indicates that circa ... in 2016 cited deficiencies in data integrity. The FDA outlines their expectations for quality ... , Presented as part of the Beckman Coulter Life Sciences Virtual Trade Show ...
(Date:8/16/2017)... Bethpage, NY (PRWEB) , ... August 16, 2017 , ... ... Kullen, Long Island’s original family-owned supermarket, has put together suggestions for enjoying the season ... new recipe or activity, everyone in the family can join in on the fun. ...
(Date:8/16/2017)... ... ... Blue Health Intelligence (BHI) announced today that Dr. Alan Spiro ... over 30 years of clinical, healthcare IT, value-based care, and change management experience to ... “I am thrilled to welcome Dr. Spiro to BHI,” said Swati Abbott, CEO of ...
(Date:8/16/2017)... (PRWEB) , ... August 16, 2017 , ... Greenfield Advisors ... companies in the U.S. for the second year in a row. The Inc. 5000 ... past three years. , “To be on the list once is a great accomplishment, ...
Breaking Medicine News(10 mins):
(Date:8/2/2017)... 2017   Marshall County Hospital in Benton, Kentucky has ... of hospital-acquired infections (HAIs). The new addition, Tru-D SmartUVC , short for "total room ... pathogens such as C. diff , MRSA, MERS, Ebola and more. ... Tru-D SmartUVC ... Tru-D in action in a patient room ...
(Date:7/31/2017)... 2017 Three Tru-D SmartUVC robots have arrived at ... . Tru-D, short for "Total Room Ultraviolet Disinfection," is a 5-foot-5 ... environmental services (ES) professional cleans the area with traditional cleaning protocols. ... Tru-D fights germs at ... "Although the BAACH has a very low ...
(Date:7/27/2017)... 27, 2017  West Pharmaceutical Services, Inc. (NYSE: ... the second-quarter 2017 and updated financial guidance for the ... 2017 Highlights Reported net sales of ... prior-year quarter. Net sales at constant currency (organic) grew ... was $0.51, compared to $0.60 in the prior-year quarter. ...
Breaking Medicine Technology: